3.15 USD
↘ 0.02 (0.63%)AT CLOSE (11:59 AM EDT)
Sana Biotechnology, Inc. Common Stock
SANANASDAQ • USD
3.15
↘ 0.01 (0.16%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
3.15
↘ 0.01 (0.16%)
Market: CLOSED
Shares of Sana Biotechnology, Inc. Common Stock (SANA) are trading at $3.13. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, SANA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 17, 2026.
Open?$3.12
High?$3.18
Low?$3.06
Prev. Close?$3.17
Volume?2.7M
Avg. Volume?3.7M
VWAP?$3.12
Rel. Volume?0.73x
Bid / Ask
Bid?$2.67 × 100
Ask?$3.16 × 200
Spread?$0.49
Midpoint?$2.92
Valuation & Ratios
Market Cap?882.2M
Shares Out?278.3M
Float?158.0M
Float %?58.5%
P/E Ratio?N/A
P/B Ratio?7.40
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Themes
Employees
142
Market Cap
882.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-04
Address
188 EAST BLAINE STREET, SUITE 350
SEATTLE, WA
Phone: (206) 701-7914
SEATTLE, WA
Phone: (206) 701-7914
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.15Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?24.50%Squeeze Risk
Short Interest?38.7M
Days to Cover?9.1
Free Float158.0M
Avg Daily Volume4.2M
Settlement Date2026-06-30
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?0.97Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?7.40FAIR▾
Peers100
S&P25
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.2CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-202.9%WEAK▾
S&P3
ROA?-64.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-133640000
Enterprise Value?$798.4M
Fundamentals ratios updated end of day